Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyVisceral SurgeryDiseaseBreast CancerColon CancerGastric CancerOvarian TumorPeritoneal Carcinomatosis, SecondarySubgroupEpCAM positiveICD10C16.-C16.0C18.0C18.2C18.3C18.4C18.5C18.6C18.7C18.8C19C50.-C56C78.6MeSHBreast NeoplasmsCarcinoma, Ovarian EpithelialColorectal NeoplasmsOvarian NeoplasmsPeritoneal NeoplasmsStomach NeoplasmsSequenceAntineoplastic therapySubstanceCatumaxomabFluorouracilNaCl 0.9%SubstanceCatumaxomabFluorouracilNaCl 0.9%SubstanceCatumaxomabFluorouracilNaCl 0.9%SubstanceCatumaxomabFluorouracilNaCl 0.9%No. Substances12 RadiotherapySupportive therapySubstanceFilgrastimGranisetronNaCl 0.9%ParacetamolSubstanceFilgrastimGranisetronNaCl 0.9%ParacetamolSubstanceFilgrastimGranisetronNaCl 0.9%ParacetamolSubstanceFilgrastimGranisetronNaCl 0.9%ParacetamolNo. Substances3Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksAnemia Hb below 8g/dlDiarrheaEmetogenicity (MASCC/ESMO)Increase AminotransferasesLymphopeniaPyrexia only studiesPublicationAuthorGhanipour LHeiss MMDiseasePeritonealkarzinose, sekundärPeritonealkarzinose, sekundär, EpCAM positivOriginCologne-Merheim Medical Center, University of Witten-Herdecke, Cologne, GermanyUppsala University, Uppsala, SwedenProtocols in Revision 2 protocols foundCatumaxomab (10/20/50/150), Peritoneal Carcinomatosis, Secondary (PID3037 V1.0)EPIC - Fluorouracil 400, Peritoneal Carcinomatosis, Secondary (PID2709 V1.0)
